Stay updated on Bepirovirsen in Chronic Hepatitis B Clinical Trial

Sign up to get notified when there's something new on the Bepirovirsen in Chronic Hepatitis B Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bepirovirsen in Chronic Hepatitis B Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the page content remains focused on study details, eligibility criteria, and locations.
    Difference
    0.2%
    Check dated 2025-11-03T12:11:45.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    The page now communicates a funding-related operating-status notice and confirms the center is open, plus a new version identifier v3.2.0, replacing v3.1.0.
    Difference
    2%
    Check dated 2025-10-05T16:40:09.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    - Page version updates to v3.1.0. - Several drug-safety related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) are removed, indicating a narrowing of scope or rebranding rather than the addition of new topics.
    Difference
    0.3%
    Check dated 2025-09-28T10:03:55.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Updated page revision from v3.0.1 to v3.0.2. Removed the 'Back to Top' element.
    Difference
    0.1%
    Check dated 2025-09-14T00:12:40.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-06T21:03:19.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations, as well as the removal of some previous location entries and related medical topics. Notably, the MedlinePlus topics have been revised to focus on drug safety and specific hepatitis conditions.
    Difference
    12%
    Check dated 2025-08-30T15:28:55.000Z thumbnail image

Stay in the know with updates to Bepirovirsen in Chronic Hepatitis B Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bepirovirsen in Chronic Hepatitis B Clinical Trial page.